Preclinical HbA1c level studies of Brihat Khadir Batika and Chandraprabha Batika after chronic administration to male Sprague-Dawley rats

Umma Hafsa Asha, Nilay Saha, Md. Mamun Sikder, Khadija Akter, Tahmina Akter Sony, Md. Hasif Sinha, Md Mahabur Rahman, M. S. K. Choudhuri


Background: Brihat Khadir Batika (BKD) and Chandraprabha Batika (CPB) are Ayurvedic preparations used as traditional medicines for different clinical indications in the rural population. BKD is used in diseases of throat and CPB is used in glandular enlargement. In this study we evaluate the influence of these preparations on HbA1c (%) level.

Methods: To find out the average plasma glucose concentration over prolonged period of time, Ayurvedic medicinal preparations BKD and CPB were administered chronically to the male Sprague-Dawley rats at a dose of 400 mg/kg. After 28 days of chronic administration of BKD and CPB the following changes were noted. In this experiment Glycated Hemoglobin A1C level was determined.

Results: The results of the study of in vitro quantitative determination of rat Glycated hemoglobin A1c concentrations in serum studies are thus: BKD caused a statistically insignificant (p=0.066) increase in the HbA1c level of the male rat (16.87% increase). CPB demonstrated a statistically insignificant (p=0.079) (17.47%) increase in the HbA1C level of the blood of the male rat.

Conclusions: Both preparation BKD and CPB found in increasing HbA1c level of the blood of the male rat.


Ayurvedic preparations, Diabetes mellitus, HbA1c, Traditional medicines

Full Text:



World Health Organization. Definition, Di gnosis and Classification of Diabetes Mellitus and its Complications. Part 1: Diagnosis and Classification of Diabetes Mellitus. WHO/NCD/NCS/99. 2nd Ed. Geneva, World Health organization, 1999.

Hanssen KF, Bangstad HJ, Brinchmann‐Hansen O, Dahl‐Jørgensen K. Blood Glucose Control and Diabetic Microvascular Complications: Long‐term Effects of Near‐normoglycaemia. Diabetic Med. 1992 Oct;9(8):697-705.

Fox CS, Coady S, Sorlie PD, D’Agostino RB, Pencina MJ, Vasan RS, et al. Increasing cardiovascular disease burden due to diabetes mellitus: the Framingham Heart Study. Circulation. 2007 Mar 27;115(12):1544-50.

Update 2015. ID F. International Diabetes Federation. Available at: 13. Archived from the original on 22 March 2016. Retrieved 21 March 2016.

Williams textbook of endocrinology, 12th ed. Shlomo Melmed Kenneth Polonsky P. Reed Larsen Henry Kronenberg. Elsevier/Saunders. 1371-1435. ISBN 978-1-4377-0324-5.

Shi Y, Hu FB. The global implications of diabetes and cancer. The lancet. 2014 Jun 7;383(9933):1947-8.

World Health Organization. Fact sheet. Diabetes. Available at: October 2013. Archived from the original on 26 August 2013. Retrieved 25 March 2014.

World Health Organization. Fact sheet: The top 10 causes of death. Available at: 2013. Archived from the original on 30 May 2017.

IDF DIABETES ATLAS. 6th Ed. International Diabetes Federation. ISBN 2930229853. Archived from the original (PDF) on 9 June 2014; 2013:7.

American Diabetes Association. Economic costs of diabetes in the US in 2012. Diabetes care. 2013 Mar 6:DC_122625.

Bangladesh National Formulary of Ayurvedic Medicine; 1992 (Approved by the Government of Bangladesh vide Ministry of Health and Family Welfare Memo No. Health-1/Unani-2/89/(Part-1) 116 dated 3-6-1991). National Unani and Ayurvedic Formulary Committee Bangladesh Board of Unani and Ayurvedic Systems of Medicine, 38, Bangabandhu Avenue, Dhaka-1000. Second ed. 2011.

Anonymous, Ayurvedic Formulary of India, The Government of India, Ministry of Health and Family Welfare, Department of Health, New Delhi. Volume I, Part I, first edition, XXXVI; 1978:324 (2nd ed., part I, XLVI and 488).

Zander R, Lang W, Wolf HU. Alkaline haematin D-575, a new tool for the determination of haemoglobin as an alternative to the cyanhaemiglobin method, I. Description of the method. Clin Chim Acta. 1984;136(1):83-93.

Robers M, Van der Hulst FF, Fischer MA, Roos W, Salud CE, Eisenwiener HG, et al. Development of a rapid microparticle-enhanced turbidimetric immunoassay for plasma fatty acid-binding protein, an early marker of acute myocardial infarction. Clinical chemistry. 1998;44(7):1564-7.

Weykamp C. HbA1c. A review of analytical and clinical aspects. Annals of laboratory medicine. 2013;33(6):393-400.

Alzahrani SH, Ajjan RA. Review article: Coagulation and fibrinolysis in diabetes. Diabetes and Vascular Disease Research. 2010;7(4):260-73.

Cavagnolli G, Comerlato J, Comerlato C, Renz P, Gross JL, Camargo JL. HbA1c measurement for the diagnosis of diabetes: is it enough? Diabetic Medicine. 2011;28(1):31-5.

Bennett CM, Guo M, Dharmage SC. HbA1c as a screening tool for detection of type 2 diabetes: a systematic review. Diabetic Medicine. 2007;24(4):333-43.

Procopiou M. HbA1c: review and recent developments. Revue Medicale Suisse. 2006;2(68):1473-4.

Ngiam KY, Lee WJ, Lee YC, Cheng A. Efficacy of metabolic surgery on HbA1c decrease in type 2 diabetes mellitus patients with BMI <35kg/m2: a review. Obesity surgery. 2014;24(1):148-58.

Karsdal MA, Krarup H, Sand JMB, Christensen PB, Gerstoft J, Leeming DJ, et al. Review article: The efficacy of biomarkers in chronic fibroproliferative diseases–early diagnosis and prognosis, with liver fibrosis as an exemplar. Alimentary pharmacology and therapeutics. 2014;40(3):233-49.

Levitan EB, Liu S, Stampfer MJ, Cook NR, Rexrode KM, Ridker PM, et al. HbA1c measured in stored erythrocytes and mortality rate among middle-aged and older women. Diabetologia. 2008;51(2):267-75.

Khan HA, Sobki SH, Khan SA. Association between glycaemic control and serum lipids profile in type 2 diabetic patients: HbA1c predicts dyslipidaemia. Clinical and experimental medicine. 2007;7(1):24-9.

Selvin E, Coresh J, Jordahl J, Boland L, Steffes MW. Stability of haemoglobin A1c (HbA1c) measurements from frozen whole blood samples stored for over a decade. Diabetic medicine. 2005;22(12):1726-30.

International Expert Committee report on the role of the A1Cassay in the diagnosis of diabetes. Diabetes Care. 2009;32:1327-34.